Metformin protects skeletal muscle from cardiotoxin induced degeneration.
The skeletal muscle tissue has a remarkable capacity to regenerate upon injury. Recent studies have suggested that this regenerative process is improved when AMPK is activated. In the muscle of young and old mice a low calorie diet, which activates AMPK, markedly enhances muscle regeneration. Remark...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4252070?pdf=render |
id |
doaj-3c2bca866fca4f7b87dfafdf5f78f7a3 |
---|---|
record_format |
Article |
spelling |
doaj-3c2bca866fca4f7b87dfafdf5f78f7a32020-11-25T02:23:37ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-01912e11401810.1371/journal.pone.0114018Metformin protects skeletal muscle from cardiotoxin induced degeneration.Francesca LangoneStefano CannataClaudia FuocoDaniele Lettieri BarbatoStefano TestaAurelio Pio NardozzaMaria Rosa CirioloLuisa CastagnoliCesare GargioliGianni CesareniThe skeletal muscle tissue has a remarkable capacity to regenerate upon injury. Recent studies have suggested that this regenerative process is improved when AMPK is activated. In the muscle of young and old mice a low calorie diet, which activates AMPK, markedly enhances muscle regeneration. Remarkably, intraperitoneal injection of AICAR, an AMPK agonist, improves the structural integrity of muscles of dystrophin-deficient mdx mice. Building on these observations we asked whether metformin, a powerful anti-hyperglycemic drug, which indirectly activates AMPK, affects the response of skeletal muscle to damage. In our conditions, metformin treatment did not significantly influence muscle regeneration. On the other hand we observed that the muscles of metformin treated mice are more resilient to cardiotoxin injury displaying lesser muscle damage. Accordingly myotubes, originated in vitro from differentiated C2C12 myoblast cell line, become more resistant to cardiotoxin damage after pre-incubation with metformin. Our results indicate that metformin limits cardiotoxin damage by protecting myotubes from necrosis. Although the details of the molecular mechanisms underlying the protective effect remain to be elucidated, we report a correlation between the ability of metformin to promote resistance to damage and its capacity to counteract the increment of intracellular calcium levels induced by cardiotoxin treatment. Since increased cytoplasmic calcium concentrations characterize additional muscle pathological conditions, including dystrophies, metformin treatment could prove a valuable strategy to ameliorate the conditions of patients affected by dystrophies.http://europepmc.org/articles/PMC4252070?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Francesca Langone Stefano Cannata Claudia Fuoco Daniele Lettieri Barbato Stefano Testa Aurelio Pio Nardozza Maria Rosa Ciriolo Luisa Castagnoli Cesare Gargioli Gianni Cesareni |
spellingShingle |
Francesca Langone Stefano Cannata Claudia Fuoco Daniele Lettieri Barbato Stefano Testa Aurelio Pio Nardozza Maria Rosa Ciriolo Luisa Castagnoli Cesare Gargioli Gianni Cesareni Metformin protects skeletal muscle from cardiotoxin induced degeneration. PLoS ONE |
author_facet |
Francesca Langone Stefano Cannata Claudia Fuoco Daniele Lettieri Barbato Stefano Testa Aurelio Pio Nardozza Maria Rosa Ciriolo Luisa Castagnoli Cesare Gargioli Gianni Cesareni |
author_sort |
Francesca Langone |
title |
Metformin protects skeletal muscle from cardiotoxin induced degeneration. |
title_short |
Metformin protects skeletal muscle from cardiotoxin induced degeneration. |
title_full |
Metformin protects skeletal muscle from cardiotoxin induced degeneration. |
title_fullStr |
Metformin protects skeletal muscle from cardiotoxin induced degeneration. |
title_full_unstemmed |
Metformin protects skeletal muscle from cardiotoxin induced degeneration. |
title_sort |
metformin protects skeletal muscle from cardiotoxin induced degeneration. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2014-01-01 |
description |
The skeletal muscle tissue has a remarkable capacity to regenerate upon injury. Recent studies have suggested that this regenerative process is improved when AMPK is activated. In the muscle of young and old mice a low calorie diet, which activates AMPK, markedly enhances muscle regeneration. Remarkably, intraperitoneal injection of AICAR, an AMPK agonist, improves the structural integrity of muscles of dystrophin-deficient mdx mice. Building on these observations we asked whether metformin, a powerful anti-hyperglycemic drug, which indirectly activates AMPK, affects the response of skeletal muscle to damage. In our conditions, metformin treatment did not significantly influence muscle regeneration. On the other hand we observed that the muscles of metformin treated mice are more resilient to cardiotoxin injury displaying lesser muscle damage. Accordingly myotubes, originated in vitro from differentiated C2C12 myoblast cell line, become more resistant to cardiotoxin damage after pre-incubation with metformin. Our results indicate that metformin limits cardiotoxin damage by protecting myotubes from necrosis. Although the details of the molecular mechanisms underlying the protective effect remain to be elucidated, we report a correlation between the ability of metformin to promote resistance to damage and its capacity to counteract the increment of intracellular calcium levels induced by cardiotoxin treatment. Since increased cytoplasmic calcium concentrations characterize additional muscle pathological conditions, including dystrophies, metformin treatment could prove a valuable strategy to ameliorate the conditions of patients affected by dystrophies. |
url |
http://europepmc.org/articles/PMC4252070?pdf=render |
work_keys_str_mv |
AT francescalangone metforminprotectsskeletalmusclefromcardiotoxininduceddegeneration AT stefanocannata metforminprotectsskeletalmusclefromcardiotoxininduceddegeneration AT claudiafuoco metforminprotectsskeletalmusclefromcardiotoxininduceddegeneration AT danielelettieribarbato metforminprotectsskeletalmusclefromcardiotoxininduceddegeneration AT stefanotesta metforminprotectsskeletalmusclefromcardiotoxininduceddegeneration AT aureliopionardozza metforminprotectsskeletalmusclefromcardiotoxininduceddegeneration AT mariarosaciriolo metforminprotectsskeletalmusclefromcardiotoxininduceddegeneration AT luisacastagnoli metforminprotectsskeletalmusclefromcardiotoxininduceddegeneration AT cesaregargioli metforminprotectsskeletalmusclefromcardiotoxininduceddegeneration AT giannicesareni metforminprotectsskeletalmusclefromcardiotoxininduceddegeneration |
_version_ |
1724858471281590272 |